Tamoxifen Suppresses Clusterin Level through Akt Inactivation and Proteasome Degradation in Human Prostate Cancer Cells |
Shim, Jae-Ho
(College of Pharmacy, Chung-Ang University)
Choi, Chang-Su (College of Pharmacy, Chung-Ang University) Lee, Eun-Chang (College of Pharmacy, Chung-Ang University) Kim, Mie-Young (College of Pharmacy, Chung-Ang University) Chun, Young-Jin (College of Pharmacy, Chung-Ang University) |
1 | Tsubuki, S., Kawasaki, H., Saito, Y., Miyashita, N., Inomata, M. and Kawashima, S. (1993). Purification and characterization of a Z-Leu-Leu-Leu-MCA degrading protease expected to regulate neurite formation: a novel catalytic activity in proteasome. Biochem. Biophys. Res. Commun. 196, 1195-1201 DOI ScienceOn |
2 | Wilson, M. R. and Easterbrook-Smith, S. B. (2000). Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 25, 95-98 DOI ScienceOn |
3 | Yoo, Y. A., Kim, Y. H., Kim, J. S. and Seo, J. H. (2008). The functional implications of Akt activity and TGF- signaling in tamoxifen-resistant breast cancer. Biochim. Biophys. Acta. 1783, 438-447 DOI ScienceOn |
4 | Zellweger, T., Chi, K., Miyake, H., Adomat, H., Kiyama, S., Skov, K. and Gleave, M. E. (2002). Enhanced radiosensitivity in prostate cancer by inhibition of the cell survival protein clusterin. Clin. Cancer Res. 8, 3276-3284 |
5 | Jones, S. E. and Jomary, C. (2002). Clusterin. Int. J. Biochem. Cell. Biol. 34, 427-431 DOI ScienceOn |
6 | Dan, H. C., Sun, M., Kaneko, S., Feldman, R. I., Nicosia, S. V., Wang, H. G., Tsang, B. K. and Cheng, J. Q. (2004). Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J. Biol. Chem. 279, 5405-5412 DOI ScienceOn |
7 | Sowery, R. D., Hadaschik, B. A., So, A. I., Zoubeidi, A., Fazli, L., Hurtado-Coll, A. and Gleave, M. E. (2008). Clusterin knockdown using the antisense oligonucleotide OGX-11 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy. BJU Int. 102, 389-397 DOI ScienceOn |
8 | Zhou, H., Li, X.-M., Meinkoth, J. and Pittman, R. N. (2000). Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell. Biol. 151, 483-494 DOI |
9 | Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J. and Greenberg, M. E. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868 DOI ScienceOn |
10 | Miyake, H., Hara, I., Gleave, M. E. and Eto, H. (2004). Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen. Prostate 61, 318-323 DOI ScienceOn |
11 | Petropoulou, C., Trougakos, I. P., Kolettas, E., Toussaint, O. and Gonos, E. S. (2001). Clusterin/apolipoprotein J is a novel biomarker of cellular senescence that does not affect the proliferative capacity of human diploid fibroblasts. FEBS Lett. 509, 287-297 DOI ScienceOn |
12 | Collard, M. W. and Griswold, M. D. (1987). Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells. Biochemistry 26, 3297-3303 DOI ScienceOn |
13 | Feng, J., Tamaskovic, R., Yang, Z., Brazil, D. P., Merlo, A., Hess, D. and Hemmings, B. A. (2004). Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation. J. Biol. Chem. 279, 35510-35517 DOI ScienceOn |
14 | Jordan, V. C. (2007). Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nat. Rev. Cancer 7, 46-53 DOI ScienceOn |
15 | Trougakos, I. P., Lourda, M., Agiostratidou, G., Kletsas, D. and Gonos, E. S. (2005). Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radic. Biol. Med. 38, 436-449 DOI ScienceOn |
16 | Zhang, H., Kim, J. K., Edwards, C. A., Xu, Z., Taichman, R. and Wang, C. Y. (2005). Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7, 909-915 DOI ScienceOn |
17 | Blaschuk, O., Burdzy, K. and Fritz, I. B. (1983). Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J. Biol. Chem. 258, 7714-7720 |
18 | Hilt, W. and Wolf, D. H. (1996). Proteasomes: destruction as a programme. Trends Biochem. Sci. 21, 96-102 DOI ScienceOn |
19 | Ammar H. and Closset, J. L. (2008). Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 283, 12851-12861 DOI ScienceOn |
20 | Bettuzzi, S., Scorcioni, F., Astancolle, S., Davalli, P., Scaltriti, M. and Corti, A. (2002). Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene 21, 4328-4334 DOI ScienceOn |
21 | Caccamo, A. E., Scaltriti, M., Caporali, A., D'Arca, D., Scorcioni, F., Candiano, G., Mangiola, M. and Bettuzzi, S. (2003). Nuclear translocation of a clusterin isoform is associated with induction of anoikis in SV40-immortalized human prostate epithelial cells. Ann. N Y Acad. Sci. 1010, 514-519 DOI ScienceOn |
22 | Cervellera, M., Raschella, G., Santilli, G., Tanno, B., Ventura, A., Mancini, C., Sevignani, C., Calabretta, B. and Sala, A. (2000). Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB. J. Biol. Chem. 275, 21055-21060 DOI ScienceOn |
23 | Chen, X., Halberg, R. B., Ehrhardt, W. M., Torrealba, J. and Dove, W. F. (2003). Clusterin as a biomarker in murine and human intestinal neoplasia. Proc. Natl. Acad. Sci. USA. 100, 9530-9535 DOI ScienceOn |
24 | Clark, A. S., West, K., Streicher, S. and Dennis, P. A. (2002). Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol. Cancer Ther. 1, 707-717 |
25 | Dumont, P., Chainiaux, F., Eliaers, F., Petropoulou, C., Remacle, J., Koch-Brandt, C., Gonos, E. S. and Toussaint, O. (2002). Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induced by ethanol and tert-butylhydroperoxide. Cell Stress Chaperones 7, 23-35 DOI ScienceOn |
26 | El Etreby, M. F., Liang, Y. and Lewis, R. W. (2000). Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture. Prostate 43, 31-42 DOI ScienceOn |
27 | Gleave, M. E., Miyake, H., Zellweger, T., Chi, K., July, L., Nelson, C. and Rennie, P. (2001). Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer. Urology 58, 39-49 DOI ScienceOn |
28 | Jordan, N. J., Gee, J. M., Barrow, D., Wakeling, A. E. and Nicholson, R. I. (2004). Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells. Breast Cancer Res Treat. 87,167-180 DOI ScienceOn |
29 | Jordan, V. C. (2006). Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer. Br. J. Pharmacol. 147, S269-S276 DOI ScienceOn |
30 | Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N. and Hay, N. (1997). The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11, 701-713 DOI |
31 | Kuo, C. C., Liu, J. F., Shiah, H. S., Ma, L. C. and Chang, J. Y. (2007) Tamoxifen accelerates proteasomal degradation of -methylguanine DNA methyltransferase in human cancer cells. Int. J. Cancer 121, 2293-2300 DOI ScienceOn |
32 | So, A., Sinnemann, S., Huntsman, D., Fazli, L. and Gleave, M. (2005). Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo. Mol. Cancer Ther. 4, 1837-1849 DOI ScienceOn |
33 | Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J. and Boothman, D. A. (2003). Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278, 11590-11600 DOI ScienceOn |
34 | Miyake, H., Nelson, C., Rennie, P. S. and Gleave, M. E. (2000). Testosterone expressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res. 60, 170-176 |
35 | Ranney, M. K., Ahmed, I. S. A., Potts, K. R. and Craven, R. J. (2007). Multiple pathways regulating the anti-apoptotic protein clusterin in breast cancer. Biochim. Biophys. Acta. 1772, 1103-1111 DOI ScienceOn |
36 | Tanno, B., Negroni, A., Vitali, R., Pirozzoli, M. C., Cesi, V., Mancini, C., Calabretta, B. and Raschellà, G. (2002). Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms. J. Biol. Chem. 277, 23172-23180 DOI ScienceOn |
37 | Trougakos, I. P., So, A., Jansen, B., Gleave, M. E. and Gonos, E. S. (2004). Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res. 64, 1834-1842 DOI ScienceOn |